RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. JSL Health Capital
J

JSL Health Capital portfolio

JSL Health Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. It is a venture capital firm based in Sarasota, US, founded in 2020. Its most recent investment on record is Precision Neuroscience's $250M Series B+ round in September 2026, alongside B Capital, ARK Investment Management, Mubadala Capital Ventures and 6 others. That company is in Health and bio. It has co-invested with Mubadala Capital Ventures, B Capital and Invus, most often Mubadala Capital Ventures (2 rounds).

Website: jslhealth.com.
Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $250M.
Latest deal: Precision Neuroscience · Sep 24, 2026.

About JSL Health Capital

Firm type: Venture capital.
Headquarters: Sarasota, US.
Founded: 2020.
Stages: Seed, Series A, Growth.
Sectors: AI & Machine Learning, Digital Health, Healthtech.

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

What JSL Health Capital invests in

How JSL Health Capital invests

StageDealsCapital in rounds
Series B+ 2 100%$250M
YearDealsCapital in rounds
2024 1 50%undisclosed
2026 1 50%$250M

Share is of the 2 rounds on Recent Funding that name JSL Health Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

JSL Health Capital portfolio companies

CompanyRound with JSL Health CapitalTotal raisedLatest raise
PPrecision Neuroscience
Health and bio
Series B+ · $250M$303MSep 24, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists JSL Health Capital, which is a subset of its real portfolio. API: /api/v1/investors/jsl-health-capital (get a free API key). More: the most active VC firms and new venture capital funds.